Rep. Byron Donalds bought The Progressive (PGR)
Rep. Byron Donalds (R-FL-19) · $1K–$15K · traded Mar 20, 2025
Why this is a committee overlap
Donalds is a member of the House Committee on Financial Services, which oversees the Financial Services sector. The Progressive is classified in the Insurance - Property & Casualty industry.
An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Mar 20, 2025
- Disclosed
- Apr 15, 2025
- Days to disclose
- 26
- Asset type
- Stock
- As filed
- Progressive Corporation
- Industry
- Insurance - Property & Casualty · Financial Services
Other trades in this filing
All of Donalds's trades →- Apr 15, 2025$1K–$15K
Sold (full) Veeva Systems VEEV
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
Sold (full) JPMorgan Chase & JPM
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Sold (full) Novo Nordisk A/S NVO
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
Sold (full) Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Bought Abbott Laboratories ABT
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
Sold (full) Robinhood Markets HOOD
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
Bought Chipotle Mexican Grill CMG
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Sold (full) JPMorgan Chase & JPM
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
Sold (full) Novo Nordisk A/S NVO
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Recent Congress trades in PGR
- Sep 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold (partial) The Progressive PGR
$1K–$15K · Traded Jul 17, 2026 · disclosed Sep 7, 2026 · filed 52 days later
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
Sold (full) The Progressive PGR
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- Jul 3, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jun 16, 2026 · disclosed Jul 3, 2026
- May 13, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 13, 2026 · Spouse
- May 8, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Apr 27, 2026 · disclosed May 8, 2026
- Apr 9, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Mar 30, 2026 · disclosed Apr 9, 2026 · Dependent
- Mar 10, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Feb 10, 2026 · disclosed Mar 10, 2026
- Feb 23, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Feb 10, 2026 · disclosed Feb 23, 2026
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.